The present disclosure is directed to compositions and methods for targeting and modulating the epigenetic “state” (e.g., methylation state) of one or more genes. For example, the present disclosure is directed, in part, to transcription activator-like effector (TALE) fusion protein compositions and methods of their use in targeting and modulating the epigenetic state of one or more genes.
